Growth momentum DNASTAR is actively expanding its software with Lasergene 19 released in 2026, signaling a sales opportunity to upsell newer features, maintenance contracts, and training packages to existing users.

Global partnerships Recent distribution alignment with ONEOMICS for South India creates a channel path to regional markets; leverage regional co-marketing, local support, and reseller incentives to accelerate regional deals.

Genomics and AI Portfolio includes Lasergene for molecular biology, genomics, and NovaFold AI, highlighting a strong AI-assisted protein structure capability; target bioinformatics teams seeking integrated AI tools and scalability.

Mid-market focus Headcount 11-50 and revenue in the 10–25M range suggests DNASTAR operates as a mid-market player; propose bundled solutions, lower TCO packages, and managed services aimed at mid-sized labs.

Thought leadership DNASTAR has a history of publishing white papers and collaborative eBooks and maintains ongoing product announcements; use this as a springboard for joint webinars, case studies, and trials to drive lead generation.